Andre potente CYP3A4- hæmmere, som fx itraconazol og HIV- proteasehæmmere, kan forventes at have lignende virkninger, og lignende dosisreduktioner bør derfor anvendes.
Other potent inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors, may be expected to have similar effects and similar dose reductions should therefore be applied.